Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Josiane V Cruz"'
Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach
Autor:
Luciane B. Silva, Elenilze F. B. Ferreira, Maryam, José M. Espejo-Román, Glauber V. Costa, Josiane V. Cruz, Njogu M. Kimani, Josivan S. Costa, José A. H. M. Bittencourt, Jorddy N. Cruz, Joaquín M. Campos, Cleydson B. R. Santos
Publikováno v:
Molecules, Vol 28, Iss 3, p 1035 (2023)
Acetylcholinesterase (AChE) enzymes play an essential role in the development of Alzheimer’s disease (AD). Its excessive activity causes several neuronal problems, particularly psychopathies and neuronal cell death. A bioactive pose on the hAChE B
Externí odkaz:
https://doaj.org/article/dc71a5ccb35141a8b7192fc4f562a8a2
Autor:
Rozires P. Leão, Josiane V. Cruz, Glauber V. da Costa, Jorddy N. Cruz, Elenilze F. B. Ferreira, Raí C. Silva, Lúcio R. de Lima, Rosivaldo S. Borges, Gabriela B. dos Santos, Cleydson B. R. Santos
Publikováno v:
Pharmaceuticals, Vol 13, Iss 9, p 209 (2020)
The cyclooxygenase-2 receptor is a therapeutic target for planning potential drugs with anti-inflammatory activity. The selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib was selected as a pivot molecule to perform virtual ligand-based screening
Externí odkaz:
https://doaj.org/article/7de64ea4b4584571a58ddd1b72a649b7
Autor:
Josiane V. Cruz, Moysés F. A. Neto, Luciane B. Silva, Ryan da S. Ramos, Josivan da S. Costa, Davi S. B. Brasil, Cleison C. Lobato, Glauber V. da Costa, José Adolfo H. M. Bittencourt, Carlos H. T. P. da Silva, Franco H. A. Leite, Cleydson B. R. Santos
Publikováno v:
Molecules, Vol 23, Iss 2, p 453 (2018)
The Protein Kinase Receptor type 2 (RIPK2) plays an important role in the pathogenesis of inflammatory diseases; it signals downstream of the NOD1 and NOD2 intracellular sensors and promotes a productive inflammatory response. However, excessive NOD2
Externí odkaz:
https://doaj.org/article/954e5774ae6d4a7a9510004fac054c88
Autor:
João Sammy Nery de Souza, Levy Bueno Alves, José M Espejo-Román, R Silva, Carlos Henrique Tomich de Paula da Silva, Njogu M. Kimani, Cleydson B. R. Santos, Silvana Giuliatti, Josiane V Cruz, Elenilze F B Ferreira
Publikováno v:
Journal of biomolecular structuredynamics. 40(12)
Cyclooxygenase 2 (COX-2) is a well-established target for the design of anti-inflammatory intermediates. Celecoxib was selected as a template molecule to perform ligand-based virtual screening, i.e. to search for structures with similarity in shape a
Autor:
Franco Henrique Andrade Leite, Joaquín M. Campos, Cleydson B. R. Santos, Njogu M. Kimani, Josiane V Cruz, Elenilze F B Ferreira, Pedro H F Araújo, Luciane B. Silva
Publikováno v:
Current medicinal chemistry. 28(29)
This article presents a simplified view of integrins with emphasis on the α4 (α4β1/VLA-4) integrin. Integrins are heterodimeric proteins expressed on the cell surface of leukocytes that participate in a wide variety of functions, such as survival,
Autor:
Ryan da Silva Ramos, Salma Saráty de Carvalho, Cleydson B. R. Santos, Josivan da Silva Costa, Daniel D. Wanderley, Carlos Henrique Tomich de Paula da Silva, Josiane V Cruz, Williams Jorge da Cruz Macêdo, Leonardo B Federico
Publikováno v:
Journal of Computational and Theoretical Nanoscience. 15:1785-1794
Autor:
Josivan da Silva Costa, Karina da Silva Lopes Costa, Carlos Henrique Tomich de Paula da Silva, Josiane V Cruz, Davi do Socorro Barros Brasil, Cleydson B. R. Santos, Ryan da Silva Ramos, Luciane B. Silva, Williams Jorge da Cruz Macêdo
Publikováno v:
Current Pharmaceutical Design
About 132 thousand cases of melanoma (more severe type of skin cancer) were registered in 2014 according to the World Health Organization. This type of cancer significantly affects the quality of life of individuals. Caffeine has shown potential inhi
Autor:
Lúcio R de Lima, Cleydson B. R. Santos, Glauber V da Costa, Gabriela Bianchi dos Santos, Josiane V Cruz, Rosivaldo S. Borges, Rozires P Leão, Jorddy Neves Cruz, Elenilze F B Ferreira, Rai C. Silva
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Pharmaceuticals
Pharmaceuticals, Vol 13, Iss 209, p 209 (2020)
Volume 13
Issue 9
Universidade de São Paulo (USP)
instacron:USP
Pharmaceuticals
Pharmaceuticals, Vol 13, Iss 209, p 209 (2020)
Volume 13
Issue 9
The cyclooxygenase-2 receptor is a therapeutic target for planning potential drugs with anti-inflammatory activity. The selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib was selected as a pivot molecule to perform virtual ligand-based screening
Autor:
Ryan da Silva Ramos, José Adolfo Homobono Machado Bittencourt, Moysés Fagundes de Araújo Neto, Franco Henrique Andrade Leite, Luciane B. Silva, Carlos Henrique Tomich de Paula da Silva, Josiane V Cruz, Davi do Socorro Barros Brasil, Glauber V da Costa, Cleydson B. R. Santos, Josivan da Silva Costa, Cleison C. Lobato
Publikováno v:
Molecules; Volume 23; Issue 2; Pages: 453
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Molecules, Vol 23, Iss 2, p 453 (2018)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Molecules, Vol 23, Iss 2, p 453 (2018)
The Protein Kinase Receptor type 2 (RIPK2) plays an important role in the pathogenesis of inflammatory diseases; it signals downstream of the NOD1 and NOD2 intracellular sensors and promotes a productive inflammatory response. However, excessive NOD2